INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
1,402,546
Share change
-1,128,855
Total reported value
$32,463,000
Price per share
$23.14
Number of holders
14
Value change
-$28,628,068
Number of buys
3
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q1 2020

As of 31 Mar 2020, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,402,546 shares. The largest 10 holders included MACKAY SHIELDS LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, CITIGROUP INC, and UBS Group AG. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.